|
Volumn 51, Issue 2, 1999, Pages 53-55
|
Prevalence of anti-HCV antibody positivity and incidence of seroconversion in patients undergoing hemodialysis;Prevalenza di positività per anticorpi antiHCV e incidenza di sieroconversione in pazienti in emodialisi
|
Author keywords
Hemodialysis, adverse effects; Hepatitis C antibodies; Hepatitis C like viruses
|
Indexed keywords
HEPATITIS C ANTIBODY;
ARTICLE;
ASEPSIS;
BLOOD;
CHRONIC KIDNEY FAILURE;
COMMUNICABLE DISEASE;
CROSS INFECTION;
DISEASE TRANSMISSION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
EPIDEMIOLOGY;
EQUIPMENT;
HEPATITIS C;
HUMAN;
INCIDENCE;
INSTRUMENTATION;
ITALY;
METHODOLOGY;
OUTPATIENT DEPARTMENT;
PREVALENCE;
RENAL REPLACEMENT THERAPY;
RETROSPECTIVE STUDY;
STANDARD;
STATISTICS;
ASEPSIS;
COMMUNITY-ACQUIRED INFECTIONS;
CROSS INFECTION;
ENZYME-LINKED IMMUNOSORBENT ASSAY;
EQUIPMENT CONTAMINATION;
HEPATITIS C;
HEPATITIS C ANTIBODIES;
HUMANS;
INCIDENCE;
ITALY;
KIDNEY FAILURE, CHRONIC;
OUTPATIENT CLINICS, HOSPITAL;
PREVALENCE;
RENAL DIALYSIS;
RETROSPECTIVE STUDIES;
SEROEPIDEMIOLOGIC STUDIES;
|
EID: 0033142139
PISSN: 03932249
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (6)
|
References (3)
|